Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals.
ADA is an enzyme implicated in purine metabolism, and is critical to ensure normal immune function. Its congenital deficit leads to severe combined immunodeficiency (SCID). ADA binding to adenosine receptors on dendritic cell surface enables T-cell costimulation through CD26 crosslinking, which enha...
Guardado en:
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2012
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/a5b2016ec1294af0bcdc5275b1d538a6 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:a5b2016ec1294af0bcdc5275b1d538a6 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:a5b2016ec1294af0bcdc5275b1d538a62021-11-18T08:05:36ZAdenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals.1932-620310.1371/journal.pone.0051287https://doaj.org/article/a5b2016ec1294af0bcdc5275b1d538a62012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23240012/?tool=EBIhttps://doaj.org/toc/1932-6203ADA is an enzyme implicated in purine metabolism, and is critical to ensure normal immune function. Its congenital deficit leads to severe combined immunodeficiency (SCID). ADA binding to adenosine receptors on dendritic cell surface enables T-cell costimulation through CD26 crosslinking, which enhances T-cell activation and proliferation. Despite a large body of work on the actions of the ecto-enzyme ADA on T-cell activation, questions arise on whether ADA can also modulate dendritic cell maturation. To this end we investigated the effects of ADA on human monocyte derived dendritic cell biology. Our results show that both the enzymatic and non-enzymatic activities of ADA are implicated in the enhancement of CD80, CD83, CD86, CD40 and CCR7 expression on immature dendritic cells from healthy and HIV-infected individuals. These ADA-mediated increases in CD83 and costimulatory molecule expression is concomitant to an enhanced IL-12, IL-6, TNF-α, CXCL8(IL-8), CCL3(MIP1-α), CCL4(MIP-1β) and CCL5(RANTES) cytokine/chemokine secretion both in healthy and HIV-infected individuals and to an altered apoptotic death in cells from HIV-infected individuals. Consistently, ADA-mediated actions on iDCs are able to enhance allogeneic CD4 and CD8-T-cell proliferation, globally yielding increased iDC immunogenicity. Taken together, these findings suggest that ADA would promote enhanced and correctly polarized T-cell responses in strategies targeting asymptomatic HIV-infected individuals.Víctor CasanovaIsaac Naval-MacabuhayMarta MassanellaMarta Rodríguez-GarcíaJulià BlancoJosé M GatellFelipe GarcíaTeresa GallartCarme LluisJosefa MallolRafael FrancoNúria ClimentPeter J McCormickPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 12, p e51287 (2012) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Víctor Casanova Isaac Naval-Macabuhay Marta Massanella Marta Rodríguez-García Julià Blanco José M Gatell Felipe García Teresa Gallart Carme Lluis Josefa Mallol Rafael Franco Núria Climent Peter J McCormick Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals. |
| description |
ADA is an enzyme implicated in purine metabolism, and is critical to ensure normal immune function. Its congenital deficit leads to severe combined immunodeficiency (SCID). ADA binding to adenosine receptors on dendritic cell surface enables T-cell costimulation through CD26 crosslinking, which enhances T-cell activation and proliferation. Despite a large body of work on the actions of the ecto-enzyme ADA on T-cell activation, questions arise on whether ADA can also modulate dendritic cell maturation. To this end we investigated the effects of ADA on human monocyte derived dendritic cell biology. Our results show that both the enzymatic and non-enzymatic activities of ADA are implicated in the enhancement of CD80, CD83, CD86, CD40 and CCR7 expression on immature dendritic cells from healthy and HIV-infected individuals. These ADA-mediated increases in CD83 and costimulatory molecule expression is concomitant to an enhanced IL-12, IL-6, TNF-α, CXCL8(IL-8), CCL3(MIP1-α), CCL4(MIP-1β) and CCL5(RANTES) cytokine/chemokine secretion both in healthy and HIV-infected individuals and to an altered apoptotic death in cells from HIV-infected individuals. Consistently, ADA-mediated actions on iDCs are able to enhance allogeneic CD4 and CD8-T-cell proliferation, globally yielding increased iDC immunogenicity. Taken together, these findings suggest that ADA would promote enhanced and correctly polarized T-cell responses in strategies targeting asymptomatic HIV-infected individuals. |
| format |
article |
| author |
Víctor Casanova Isaac Naval-Macabuhay Marta Massanella Marta Rodríguez-García Julià Blanco José M Gatell Felipe García Teresa Gallart Carme Lluis Josefa Mallol Rafael Franco Núria Climent Peter J McCormick |
| author_facet |
Víctor Casanova Isaac Naval-Macabuhay Marta Massanella Marta Rodríguez-García Julià Blanco José M Gatell Felipe García Teresa Gallart Carme Lluis Josefa Mallol Rafael Franco Núria Climent Peter J McCormick |
| author_sort |
Víctor Casanova |
| title |
Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals. |
| title_short |
Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals. |
| title_full |
Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals. |
| title_fullStr |
Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals. |
| title_full_unstemmed |
Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals. |
| title_sort |
adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and hiv-infected individuals. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2012 |
| url |
https://doaj.org/article/a5b2016ec1294af0bcdc5275b1d538a6 |
| work_keys_str_mv |
AT victorcasanova adenosinedeaminaseenhancestheimmunogenicityofhumandendriticcellsfromhealthyandhivinfectedindividuals AT isaacnavalmacabuhay adenosinedeaminaseenhancestheimmunogenicityofhumandendriticcellsfromhealthyandhivinfectedindividuals AT martamassanella adenosinedeaminaseenhancestheimmunogenicityofhumandendriticcellsfromhealthyandhivinfectedindividuals AT martarodriguezgarcia adenosinedeaminaseenhancestheimmunogenicityofhumandendriticcellsfromhealthyandhivinfectedindividuals AT juliablanco adenosinedeaminaseenhancestheimmunogenicityofhumandendriticcellsfromhealthyandhivinfectedindividuals AT josemgatell adenosinedeaminaseenhancestheimmunogenicityofhumandendriticcellsfromhealthyandhivinfectedindividuals AT felipegarcia adenosinedeaminaseenhancestheimmunogenicityofhumandendriticcellsfromhealthyandhivinfectedindividuals AT teresagallart adenosinedeaminaseenhancestheimmunogenicityofhumandendriticcellsfromhealthyandhivinfectedindividuals AT carmelluis adenosinedeaminaseenhancestheimmunogenicityofhumandendriticcellsfromhealthyandhivinfectedindividuals AT josefamallol adenosinedeaminaseenhancestheimmunogenicityofhumandendriticcellsfromhealthyandhivinfectedindividuals AT rafaelfranco adenosinedeaminaseenhancestheimmunogenicityofhumandendriticcellsfromhealthyandhivinfectedindividuals AT nuriacliment adenosinedeaminaseenhancestheimmunogenicityofhumandendriticcellsfromhealthyandhivinfectedindividuals AT peterjmccormick adenosinedeaminaseenhancestheimmunogenicityofhumandendriticcellsfromhealthyandhivinfectedindividuals |
| _version_ |
1718422249042608128 |